No Data
No Data
What's in Store for These 5 Biotech Stocks This Earnings Season?
Intellia Therapeutics (NASDAQ:NTLA) Shareholders Are up 14% This Past Week, but Still in the Red Over the Last Three Years
Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?
Intellia Therapeutics to Present Q4 and Full-Year 2024 Financial Results on February 27, 2025
Earnings Week Ahead: BABA, XYZ, BIDU, WMT, RIVN and More
$NTLA Stock Is up 9% Today. Here's What We See in Our Data.
DD07 : is it still an entry position